NOCIL

Why is NOCIL Ltd falling/rising?

As of 14-Jun, NOCIL Ltd's stock price is rising to 161.55, driven by positive market sentiment and increased institutional investment. However, the company faces significant long-term challenges, including six consecutive quarters of negative results and a decline in operating profit.

As of 14-Jun, NOCIL Ltd's stock price is rising, currently at 161.55, reflecting an increase of 5.55 or 3.56%. This rise can be attributed to several factors. Firstly, the stock has outperformed its sector by 2.01% today, indicating positive market sentiment. It also reached an intraday high of Rs 162, which is a 3.85% increase. Additionally, there has been increasing participation from institutional investors, who have raised their stake by 1.49% over the previous quarter, now holding 12.46% of the company. This suggests a growing confidence among more sophisticated investors, who typically have better resources to analyze company fundamentals.<BR><BR>However, it is important to note that despite the current rise, NOCIL Ltd has faced significant challenges over the long term. The company has reported negative results for the last six consecutive quarters, with a decline in operating profit at an annual rate of -13.10% over the past five years. The stock has also underperformed against the benchmark indices, generating a return of -19.61% over the last year, while profits have fallen by -42.3%. <BR><BR>In summary, while NOCIL Ltd's stock is currently rising due to positive short-term performance and increased institutional interest, it faces substantial long-term challenges that could affect its sustainability.

Which are the latest news on NOCIL?

How big is NOCIL?

As of 10th June, NOCIL Ltd has a market capitalization of 2,652.00 Cr, with net sales of 1,302.97 Cr and a net profit of 55.63 Cr reported in the latest four quarters. Shareholder's funds are 1,762.24 Cr, and total assets are 2,057.04 Cr as of March 2025.

As of 10th June, NOCIL Ltd has a market capitalization of 2,652.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, NOCIL reported net sales of 1,302.97 Cr and a net profit of 55.63 Cr.<BR><BR>For the latest annual period ending in March 2025, NOCIL's shareholder's funds amounted to 1,762.24 Cr, while total assets were reported at 2,057.04 Cr.

Who are in the management team of NOCIL?

The management team of NOCIL includes Hrishikesh A Mafatlal (Executive Chairman), S R Deo and Anand V.S (Managing Directors), along with several independent directors and a Company Secretary, Amit K Vyas, bringing diverse expertise to the company.

The management team of NOCIL includes the following individuals:<BR><BR>1. Hrishikesh A Mafatlal - Executive Chairman<BR>2. S R Deo - Managing Director<BR>3. Anand V.S - Managing Director<BR>4. Rohit Arora - Independent Director<BR>5. V R Gupte - Director<BR>6. D N Mungale - Independent Director<BR>7. P V Bhide - Independent Director<BR>8. Dharmishta Narendraprasad Raval - Independent Director<BR>9. Priyavrata H Mafatlal - Director<BR>10. Debnarayan Bhattacharya - Independent Director<BR>11. A Vellayan - Independent Director<BR>12. Radhika Haribhakti - Independent Director<BR>13. Amit K Vyas - Company Secretary & Compliance Officer<BR><BR>This team brings a diverse range of expertise and leadership to the company.

Who are the peers of the NOCIL?

NOCIL's peers include Yasho Industries, Rossari Biotech, Jubilant Agri, Tatva Chintan, DDev Plastiks, Camlin Fine, Bhansali Engg., Titan Biotech, S H Kelkar & Co., and Vidhi Specialty. In terms of management risk, growth, and capital structure, NOCIL is rated average, with a 1-year return of -22.99%.

Peers: The peers of NOCIL are Yasho Industries, Rossari Biotech, Jubilant Agri, Tatva Chintan, DDev Plastiks, Camlin Fine, Bhansali Engg., Titan Biotech, S H Kelkar & Co., and Vidhi Specialty.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rossari Biotech, while Average management risk is found at Yasho Industries, Jubilant Agri, NOCIL, Tatva Chintan, DDev Plastiks, Bhansali Engg., Titan Biotech, S H Kelkar & Co., and Vidhi Specialty, and Below Average management risk is noted at Camlin Fine. Growth is Excellent at Jubilant Agri, Good at DDev Plastiks, Average at Rossari Biotech, and the rest have Below Average growth. Capital Structure is Excellent at Rossari Biotech, Jubilant Agri, NOCIL, Tatva Chintan, DDev Plastiks, Bhansali Engg., Titan Biotech, and Vidhi Specialty, while Average is seen at S H Kelkar & Co., and Below Average at Yasho Industries and Camlin Fine.<BR><BR>Return Snapshot: Titan Biotech has the highest 1-year return at 412.73%, while Camlin Fine has the lowest at -57.63%. NOCIL's 1-year return of -22.99% is significantly lower than Titan Biotech's and higher than Camlin Fine's. Additionally, the six-month return is negative for Rossari Biotech, Jubilant Agri, DDev Plastiks, Camlin Fine, S H Kelkar & Co., and Vidhi Specialty.

What does NOCIL do?

NOCIL Ltd is India's largest manufacturer of rubber chemicals, part of the Arvind Mafatlal Group, with a market cap of INR 2,652 Cr and reported net sales of 330 Cr and net profit of 17 Cr for Q1 2026. Key metrics include a P/E ratio of 44.00 and a dividend yield of 1.27%.

Overview:<BR>NOCIL Ltd is India's largest manufacturer and supplier of rubber chemicals, operating in the specialty chemicals industry within the small-cap market segment.<BR><BR>History:<BR>NOCIL Ltd is part of the Arvind Mafatlal Group of Industries and has been engaged in the manufacturing and sale of rubber chemicals. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 330 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 17 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 2,652 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 44.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 1.27%<BR>- Debt Equity: -0.19<BR>- Return on Equity: 3.35%<BR>- Price to Book: 1.48<BR><BR>Contact Details:<BR>Address: Mafatlal House H T Parekh Marg, Backbay Reclamation Churchgate Mumbai Maharashtra : 400020<BR>Tel: 91-022-66364062<BR>Email: investorcare@nocilindia.com<BR>Website: http://www.nocil.com

Should I buy, sell or hold NOCIL Ltd?

Are NOCIL Ltd latest results good or bad?

NOCIL Ltd's latest results show an 83.78% quarter-on-quarter profit increase, but year-on-year declines in both net profit and revenue raise concerns. The falling operating margin and reliance on non-operating income suggest underlying challenges, leading to a cautiously pessimistic outlook.

NOCIL Ltd's latest results present a mixed picture. On one hand, the company reported a significant quarter-on-quarter net profit growth of 83.78%, reaching ₹17.00 crores, which is a positive sign. Additionally, revenue increased by 4.59% sequentially to ₹330.35 crores. However, these figures are somewhat misleading when considering the year-on-year performance; both net profit and revenue saw declines of 18.23% and 2.75%, respectively.<BR><BR>The operational metrics reveal deeper concerns. The operating margin has fallen to 6.37%, marking a multi-quarter low and reflecting ongoing challenges in maintaining profitability. This decline in margins, coupled with a heavy reliance on non-operating income (which constituted 66.35% of profit before tax), raises questions about the sustainability of earnings.<BR><BR>Overall, while there are signs of short-term recovery in profits, the underlying operational issues and declining margins suggest that the results are not as strong as they may initially appear. The company faces significant challenges that could impact its future performance, making the outlook cautiously pessimistic.

Is Nocil technically bullish or bearish?

As of November 27, 2025, Nocil's stock trend has shifted to bearish, currently priced at 171.75 after a 34.11% decline over the past year, with recent performance showing an 8.16% drop in the last month.

As of 27 November 2025, the technical trend for Nocil has changed from mildly bearish to bearish. The current price is 171.75, down from the previous close of 175.50, indicating a downward movement. The stock has experienced a significant decline over the past year, down 34.11%, while the Sensex has gained 6.84%. The 52-week high of 293.80 and low of 155.00 further highlight the volatility and current bearish stance. The recent performance shows a negative return of 8.16% over the past month, reinforcing the bearish outlook. Overall, the indicators suggest a bearish stance with weak momentum.

Is Nocil overvalued or undervalued?

As of November 10, 2025, Nocil is considered very expensive and overvalued with a PE ratio of 45.66 and a year-to-date return of -29.26%, significantly underperforming compared to the Sensex's gain of 6.91%.

As of 10 November 2025, Nocil's valuation grade has moved from expensive to very expensive, indicating a significant shift in its market perception. The company is currently overvalued, with a PE ratio of 45.66, an EV to EBITDA ratio of 23.51, and a Price to Book Value of 1.63. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Nocil's valuation stands out as particularly high; for instance, Solar Industries has a PE ratio of 96.11 and an EV to EBITDA of 59.13, while Godrej Industries, considered attractive, has a PE of 35.42 and an EV to EBITDA of 28.71. The overall trend in Nocil's stock performance has been negative, with a year-to-date return of -29.26%, contrasting sharply with the Sensex's gain of 6.91% during the same period. This further reinforces the conclusion that Nocil is overvalued in the current market environment.

How has been the historical performance of Nocil?

Nocil's historical performance has shown a decline in net sales and profitability from March 2023 to March 2025, with net sales dropping from INR 1,616.57 crore to INR 1,392.69 crore and profit after tax decreasing from INR 149.15 crore to INR 102.86 crore. Additionally, cash flow from operating activities fell significantly, indicating volatility in financial performance.

Answer:<BR>The historical performance of Nocil shows a fluctuating trend in key financial metrics over the years leading up to March 2025.<BR><BR>Breakdown:<BR>Nocil's net sales have seen a decline from INR 1,616.57 crore in March 2023 to INR 1,392.69 crore in March 2025, with a peak in March 2023. Total operating income followed a similar trend, decreasing from INR 1,616.57 crore in March 2023 to INR 1,392.69 crore in March 2025. The raw material cost increased slightly to INR 798.44 crore in March 2025 from INR 783.01 crore in March 2024, while total expenditure (excluding depreciation) remained relatively stable at INR 1,255.28 crore in March 2025. Operating profit (PBDIT) decreased significantly from INR 258.97 crore in March 2023 to INR 169.51 crore in March 2025, reflecting a declining operating profit margin from 15.63% to 9.87%. Profit before tax also fell from INR 202.09 crore in March 2023 to INR 114.14 crore in March 2025, leading to a profit after tax of INR 102.86 crore in March 2025, down from INR 149.15 crore in March 2023. The company's total assets increased to INR 2,057.04 crore in March 2025 from INR 1,857.09 crore in March 2023, while total liabilities also rose to INR 2,057.04 crore in March 2025. Cash flow from operating activities decreased significantly to INR 25 crore in March 2025 from INR 281 crore in March 2023, resulting in a net cash outflow of INR 61 crore in March 2025. Overall, Nocil's financial performance has shown volatility with a notable decline in profitability and cash flow in recent years.

Who are the top shareholders of the Nocil?

The top shareholders of Nocil include Hrishikesh Arvind Mafatlal with 18.16%, individual investors holding 42.88%, and foreign institutional investors at 8.15%. Notably, 10.33% of promoter holdings are pledged, and the highest public shareholder is Tejas Trivedi with 1.88%.

The top shareholders of Nocil include Hrishikesh Arvind Mafatlal, who holds the highest stake as a trustee of Gurukripa Trust with 18.16%. The company also has a significant portion of individual investors holding 42.88%. Additionally, 10.33% of the promoter holdings are pledged. Mutual funds hold 4.0% through 13 schemes, while foreign institutional investors (FIIs) account for 8.15% with 105 FIIs involved. The highest public shareholder is Tejas Trivedi, who holds 1.88%.

When is the next results date for Nocil?

No Upcoming Board Meetings

Has Nocil declared dividend?

Nocil Ltd. has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of July 26, 2024. While the dividend yield is 1.54%, total returns have varied significantly, showing declines in the short term but a strong recovery over the longer term.

Nocil Ltd. has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3 per share<BR>- Ex-date: 26 Jul 24<BR><BR>Dividend Yield: 1.54%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -30.45%, with a dividend return of 0%, resulting in a total return of -30.45%.<BR><BR>Over the past year, the price return was -20.52%, the dividend return was 1.12%, leading to a total return of -19.4%.<BR><BR>In the 2-year period, the price return was -9.04%, the dividend return was 2.74%, resulting in a total return of -6.3%.<BR><BR>For the 3-year period, the price return was -24.63%, with a dividend return of 3.79%, culminating in a total return of -20.84%.<BR><BR>In the last 4 years, the price return was -2.95%, the dividend return was 5.12%, resulting in a total return of 2.17%.<BR><BR>Over the 5-year period, the price return was 129.28%, with a dividend return of 12.51%, leading to a total return of 141.79%.<BR><BR>Overall, while Nocil Ltd. has declared a dividend, the total returns over various periods show a mixed performance, with significant declines in the shorter terms but a strong recovery in the longer term. The dividend yield indicates a modest return relative to the stock price.